The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Phase I trial of cabazitaxel plus cisplatin in patients with advanced solid tumors.
Albert C. Lockhart
Research Funding - Allos Therapeutics; Amgen; Bayer; Cephalon; ImClone Systems; Keryx; Merck; Millennium; Novartis; Pfizer; Sanofi
Shankar Sundaram
No relevant relationships to disclose
John Sarantopoulos
No relevant relationships to disclose
Monica M. Mita
No relevant relationships to disclose
Alex R. Lane
No relevant relationships to disclose
Jennifer L. Moseley
No relevant relationships to disclose
Jean-Francois Dedieu
Employment or Leadership Position - Sanofi
Stock Ownership - Sanofi
Diane Stash
Employment or Leadership Position - Sanofi
Xin Zhi
Employment or Leadership Position - Sanofi
Stock Ownership - Sanofi
Florent Mazuir
Employment or Leadership Position - Sanofi
Stock Ownership - Sanofi
Alain C. Mita
No relevant relationships to disclose